AHK-Cu (Copper Tripeptide-2) Research Overview

Simplified Summary

AHK-Cu is a copper-binding tripeptide comprising the amino acid sequence alanine-histidine-lysine, chelated to copper in the same chemical class as the better-characterised GHK-Cu (glycine-histidine-lysine copper). Like GHK-Cu, it utilises the histidine residue for copper coordination, but its different flanking amino acids produce a distinct biological activity profile with particular relevance to follicular biology.

In vitro research using dermal papilla cells has examined AHK-Cu's potential to activate the cellular populations responsible for hair follicle cycling and growth. Dermal papilla cells are the dermal signalling centres of hair follicles — their activation is considered a research target for follicular support applications. Most AHK-Cu research involves topical application rather than systemic administration.

Evidence for AHK-Cu effects is limited primarily to in vitro cell culture studies and some topical formulation research. Unlike GHK-Cu, which has a broader research base spanning wound healing, skin remodelling, and anti-ageing applications, AHK-Cu's research literature is narrower and more specifically directed toward follicular biology.

Key Findings Reported in Research Models

• Dermal papilla cell activation: In vitro studies have examined AHK-Cu's effects on dermal papilla cell proliferation and expression of follicle-related markers, supporting the rationale for topical follicular applications.
• Copper-dependent mechanism: Like all copper peptides, AHK-Cu's biological activity is dependent on copper coordination — research has characterised the compound's copper-binding properties relative to GHK-Cu and other copper tripeptides.
• Topical formulation stability: Research into optimal concentrations (0.05–0.2%) and formulation conditions (glass containers required due to copper-plastic binding) has been conducted to support consistent topical delivery.
• Scalp tissue tolerability: Clinical and in vitro studies have characterised the expected skin response, including initial scalp irritation in some individuals that typically resolves within the first weeks of use.
• Comparison with GHK-Cu: Comparative studies have examined the different activity profiles of AHK-Cu and GHK-Cu, with AHK-Cu demonstrating more selective follicular activity and GHK-Cu showing broader tissue-remodelling effects.

Introduction

AHK-Cu was developed as an alternative copper tripeptide with a distinct amino acid composition from the canonical GHK-Cu. The histidine residue at the central position is conserved between the two compounds and is the primary copper-coordination site. The flanking alanine and lysine (vs. glycine and lysine in GHK-Cu) produce different peptide geometry and binding interactions.

The cosmetic research interest in AHK-Cu stems from its in vitro effects on dermal papilla cells — specialised mesenchymal cells in the hair follicle base that are critical for follicular growth phase initiation. Compounds that activate these cells are of interest in scalp and hair biology research.

A critical formulation consideration is the well-characterised tendency of copper ions to bind to plastic surfaces. Research and topical application protocols specify glass containers to prevent copper loss and maintain the AHK-Cu complex integrity over storage periods.

Research Applications

• Follicular biology research: In vitro dermal papilla cell studies examining the effects of copper tripeptide compounds on hair follicle cycling markers and follicular growth signalling.
• Copper peptide comparative research: Studies comparing the activity profiles of different copper-binding peptides (AHK-Cu, GHK-Cu, GHK) across skin, scalp, and cellular remodelling contexts.
• Topical delivery research: Formulation studies examining optimal concentration ranges, vehicle selection, and stability characteristics for copper tripeptide topical preparations.